Enzyme kinetics noncompetitive inhibition

If the inhibitor combines irreversibly with the enzyme—for example, by covalent attachment—the kinetic pattern seen is like that of noncompetitive inhibition, because the net effect is a loss of active enzyme. Usually, this type of inhibition can be distinguished from the noncompetitive, reversible inhibition case since the reaction of I with E (and/or ES) is not instantaneous. Instead, there is a time-dependent decrease in enzymatic activity as E + I El proceeds, and the rate of this inactivation can be followed. Also, unlike reversible inhibitions, dilution or dialysis of the enzyme inhibitor solution does not dissociate the El complex and restore enzyme activity. 

Uncompetitive antagonism, form of inhibition (originally defined for enzyme kinetics) in which both the maximal asymptotic value of the response and the equilibrium dissociation constant of the activator (i.e., agonist) are reduced by the antagonist. This differs from noncompetitive antagonism where the affinity of the receptor for the activating drug is not altered. Uncompetitive effects can occur due to allosteric modulation of receptor activity by an allosteric modulator (see Chapter 6.4). 

Because noncompetitive inhibitors bind to both the free enzyme and the ES complex, or subsequent species in the reaction pathway, we would expect these molecules to exert a kinetic effect on the E + S —> ES" process, thus effecting the apparent values of both VmdX/KM (influenced by both the K and al, terms) and Vmax (influenced by the aK term). This is reflected in the velocity equation for noncompetitive inhibition ... 

In addition to the binding of substrate (or in some cases co-substrates) at the active site, many enzymes have the capacity to bind regulatory molecules at sites which are usually spatially far removed from the catalytic site. In fact, allosteric enzymes are invariably multimeric (i.e. have a quaternary structure) and the allosteric (regulatory) sites are on different subunits of the protein to the active site. In all cases, the binding of the regulatory molecules is non covalent and is described in kinetic terms as noncompetitive inhibition. 

Enzyme inhibition by an extremely tight-binding inhibi-tor When the substrate(s), regardless of the detailed mode of inhibition, has (have) a negligible effect on the formation of enzyme-inhibitor (E-I) complex, the net result is depletion i.e., the removal of enzyme by the inhibitor from the reaction). The observed kinetic pattern is identical to the simple noncompetitive inhibition case the substrate and the inhibitor do not affect each other s binding, because only V sk is changed due to reduced enzyme concentration, while remains unaltered. 

The rate equation to be used for kinetic analysis of enzyme depletion is that for simple noncompetitive inhibition. If the Henderson equation or similar types are not employed, keep in mind that the inhibitor concentration [I] is the free inhibitor concentration. Determination of Ki may not be feasible if the rate assay is insensitive and requires an enzyme concentration much greater than K[. Alternatively, Ki may be obtained by measuring the on-off rate constants of the E l complex, provided the rate constants for any conformation change steps involved are also known. 

Inhibition studies involving ALR2 have indicated noncompetitive inhibition for virtually all compounds examined to date when the forward (reduction) reaction is monitored. This mode of inhibition is often interpreted as meaning that the inhibitor binds to a site on the enzyme that is independent of the catalytic site. Kinetic and competition studies have both led to this conclusion in the case of ALR2 [24,25]. The crystal structure of the enzyme complexed with both the NADPH cofactor and zopolrestat, however, clearly shows the inhibitor occupying the region directly above the nicotinamide of the NADPH and, therefore, the active site (Figures 5, 6, and 7). 

Product inhibition (Section A,12) can also provide information about mechanisms. For example, if 1 / v is plotted against 1 / [A] in the presence and absence of the product Q, the product will be found to compete with A and to give a typical family of lines for competitive inhibition. On the other hand, a plot of 1 / v vs 1 / [B] in the presence and absence of Q will indicate noncompetitive inhibition if the binding of substrates is ordered (Eq. 9-43). In other words, only the A-Q pair of substrates are competitive. Product inhibition is also observed with enzymes having ping-pong kinetics (Eq. 9-47) as a result of formation of nonproductive complexes. 

Inhibition kinetics are included in the second category of assay applications. An earlier discussion outlined the kinetic differentiation between competitive and noncompetitive inhibition. The same experimental conditions that pertain to evaluation of Ku and Vmax hold for A) estimation. A constant level of inhibitor is added to each assay, but the substrate concentration is varied as for Ku determination. In summary, a study of enzyme kinetics is approached by measuring initial reaction velocities under conditions where only one factor (substrate, enzyme, cofactor) is varied and all others are held constant. 

Prostatic acid phosphatase is partially and reversibly inactivated by calcium ion (45). Anions such as chloride, bromide, and thiocyanate inhibit prostatic acid phosphatase competitively with regard to substrate as well as noncompetitively. A kinetic analysis by London et al. (46) indicates that the noncompetitive inhibition was related to changes in charge on the protein molecule. A variety of nonspecific anions accelerate thermal denaturation of the enzyme. The enzyme is quite sensitive to a number of electrolyte changes, but it is not clear whether these factors are involved in biological control. 

The primary considerations in studies of inhibition mechanisms are reversibility and selectivity. The inhibition kinetics of reversible inhibition give considerable insight into the reaction mechanisms of enzymes and, for that reason, have been well studied. In general, reversible inhibition involves no covalent binding, occurs rapidly, and can be reversed by dialysis or, more rapidly, by dilution. Reversible inhibition is usually divided into competitive inhibition, uncompetitive inhibition, and noncompetitive inhibition. Because these types are not rigidly separated, many intermediate classes have been described. 

Competitive inhibition occurs, when substrate and inhibitor compete for binding at the same active site at the enzyme. Based on the Michaelis-Menten kinetics, Vmax is unchanged whereas Km increases. In case of noncompetive inhibition, the inhibitor and the substrate bind to different sites at the enzyme. Vmax decrease whereas the Km value is unaffected. Binding of the inhibitor only to the enzyme-substrate complex is described as uncompetitive inhibition. Both, Vmax and Km decrease. Finally, mixed (competitive-noncompetitive) inhibition occurs, either the inhibitor binds to the active or to another site on the enzyme, or the inhibitor binds to the active site but does not block the binding of the substrate. 

Other inhibition models of NH4 and NO3 uptake have been based on enzyme kinetics (e.g., noncompetitive inhibition Frost and Franzen (1992)). Whether or not the analogy is strictly applicable, this would appear to have a more sound biological basis than the Wroblewski (1977) exponential function. Yajnik and Sharada (2003) defined general equations for a two-nutrient interaction that can be reduced to hyperbolic inhibition such as that employed by Frost and Franzen (1992) and Parker (1993). 

This article describes various approaches to inhibition of enzyme catalysis. Reversible inhibition includes competitive, uncompetitive, mixed inhibition, noncompetitive inhibition, transition state, and slow tight-binding inhibition. Irreversible inhibition approaches include affinity labeling and mechanism-based enzyme inhibition. The kinetics of the various inhibition approaches are summarized, and examples of each type of Inhibition are presented. 

Michaelis-Menten kinetics and, depending on their preference of binding to the free enzyme and/or the enzyme-substrate complex, competitive, uncompetitive, and noncompetitive inhibition patterns can be distinguished. For the purposes of this discussion it will be assumed that the initial equilibrium of free and bound substrate is established significantly faster than the rate of the chemical transformation of substrate to product, that is,... 

Sometimes steady-state kinetics are insufficient to analyze the mechanism of inactivation for a given inhibitor. For example, irreversible enzyme inhibitors that bind so tightly to the enzyme that their dissociation rate ( ff) is effectively zero also exhibit noncompetitive inhibition patterns. They act by destroying a portion of the enzyme through irreversible binding, thereby lowering the overall enzyme concentration and decreasing Vmax- The apparent Km remains unaffected because irre-... 

Figure 8.38. Noncompetitive Inhibition Illustrated on a Double-Reciprocal Plot. A double-reciprocal plot of enzyme kinetics in the presence ( and absence of a noncompetitive inhibitor shows thatiT is unaltered and...

Fig. 3. p-Glucosidase inhibition shown by Lineweaver-Burk plot (reproduced from [2]). Lineweaver-Burk plot of kinetic data from peak 2 cellobiase ((3-glucosidase) at several product inhibitor levels. This is an example of noncompetitive inhibition where the product is not only completing for binding in the active site but also binding to a secondary site on the enzyme that alters the enzyme catalytic ability... 

How can we determine whether a reversible inhibitor acts by competitive or noncompetitive inhibition Let us consider only enzymes that exhibit Michaelis- Menten kinetics. Measurements of the rates of catalysis at different concentrations of substrate and inhibitor serve to distinguish the three types of inhibition. In competitive inhibition, the inhibitor competes with the substrate for the active site. The dissociation constant for the inhibitor is given by... 

In textbooks dealing with enzyme kinetics, it is customary to distinguish four types of reversible inhibitions (i) competitive (ii) noncompetitive (iii) uncompetitive and, (iv) mixed inhibition. Competitive inhibition, e.g., given by the product which retains an affinity for the active site, is very common. Non-competitive inhibition, however, is very rarely encountered, if at all. Uncompetitive inhibition, i.e. where the inhibitor binds to the enzyme-substrate complex but not to the free enzyme, occurs also quite often, as does the mixed inhibition, which is a combination of competitive and uncompetitive inhibitions. The simple Michaelis-Menten equation can still be used, but with a modified Ema, or i.e. ... 

The answer is c. (Murray, pp 48-73. Scriver, pp 4571-4636. Sack, pp 3-17. Wilson, pp 287-317.) Allosteric enzymes, unlike simpler enzymes, do not obey Michaelis-Menten kinetics. Often, one active site of an allosteric enzyme molecule can positively affect another active site in the same molecule. This leads to cooperativity and sigmoidal enzyme kinetics in a plot of [S] versus V The terms competitive inhibition and noncompetitive inhibition apply to Michaelis-Menten kinetics and not to allosteric enzymes. 

Inhibitors structurally related to the substrate may be bound to the enzyme active center and compete with the substrate (competitive inhibition). If the inhibitor is not only bound to the enzyme but also to the enzyme-substrate complex, the active center is usually deformed and its function is thus impaired in this case the substrate and the inhibitor do not compete with each other (noncompetitive inhibition). Competitive and noncompetitive inhibition effect the enzyme kinetics differently. A competitive inhibitor does not change but increases. Km (Fig. 25a) in contrast, noncompetitive inhibition results in an unchanged Km and an increased vmax (Fig. 25b). Some enzymes, e.g. invertase, are inhibited by high product concentration (product inhibition). 

Fig. 26. Kinetics of enzyme-catalyzed reactions with (a) competitive, and (b) noncompetitive inhibition.

The kinetic properties of these multiple forms are quite similar (Farooqui, 1976b). With p-nitrocatechol sulfate as substrate, arylsulfohydrolase B has a value at least three times higher than that of arylsulfohydrolase A. Sulfate ions produce a noncompetitive inhibition of this enzyme with a K value of... 

The kinetics of AR inhibition by several inhibitors have been studied the flavonoids quercitrin [28] and axillarin [29], as well as sulindac [111], alrestatin [28], indomethacin [111], and -bromophenylsulphonylhydantoin [84], have been shown to be noncompetitive inhibitors. In addition, epalrestat [90], sorbinil [113, 114], TMG [115], 7-hydroxy-4-oxo-4//-chromene-6-car-boxylic acid [32] and statil [95] were found to exhibit mixed uncompetitive-noncompetitive inhibition. Hence, these and other AR inhibitors [116] do not compete for the substrate-binding site on the enzyme. Furthermore, other studies show that various AR inhibitors do not compete for the nucleotide-cofactor-binding site [114,116]. 

---